Bernd Merkl

Bernd Merkl is the Business Unit Director for Mycobacteria and TB at Bruker. With over 25 years’ experience in the diagnostic and life science industry, Bernd has occupied leadership positions at a range of companies from start-ups to larger organizations. Bernd completed a Master’s degree in Biology & Chemistry at FAU Erlangen-Nürnberg, and later a Master’s in Business Administration at the University of Regensburg.

  • GD01 strain of Mycobacteroides abscessus isolated from patient
    Features

    The growing threat of nontuberculous mycobacteria infections

    2025-06-02T08:58:00

    Once overlooked, NTM are now drawing increased attention as their infections pose significant and complex diagnostic challenges. Advances in diagnostic technologies offer the potential to overcome these hurdles to enable precise species-level detection, guide targeted therapy.